Advancing Product Candidates
canvas quality fashion 2017 high shoes men v4qFxwf from Our Own Pipeline
A Simple Elegant Solution for Addressing Challenges in Drug Delivery
men for China sale direct shoes factory from big derbies guangzhou
Actively Partnering with
Liquidia Technologies is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. Currently, Liquidia is developing two product candidates from its own pipeline: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. In addition to developing our own product candidates, Liquidia collaborates with leading pharmaceutical companies to apply our PRINT technology across a wide range of therapeutic areas, molecule types and routes of administration.